NURSE NETWORK
Welcome to the ViiV UK Nurse Network Here you'll find useful resources for Vocabria and Rekambys long-acting injectables for nurses written by nurses.

Nurses are key in developing and managing the delivery of Vocabria and Rekambys for people living with HIV. They know people well, spending more time with them and therefore gaining a deep meaningful understanding of their medical & psychosocial needs.
UK nurses have developed useful resources, which include:
- Top tips when implementing Vocabria and Rekambys: bringing to life how UK nurses run their HIV injectable service, considering what has worked well and where there is room for improvement.
- Case studies which show people's experience on Vocabria and Rekambys and also demonstrate the nurses’ role in patient identification.
Hopefully these resources resonate with you and show what is happening with real people in the UK. They are representative of different areas of the UK, in both small and large clinic-settings as well as the community. We hope they support you with implementation of your own injectable HIV service.
Meet the UK ViiV Nurse Specialist Advisor Team
Send us your feedback and suggestions,
Email us any feedback or suggestions on what you would like to see from the Nurse Network in future. Once you have submitted this, we at ViiV Healthcare UK will review and take onboard for future!
REKAMBYS (rilpivirine long-acting injection), including the trademark is owned by the Janssen Pharmaceutical Companies and used under license by the ViiV Healthcare group of companies. All other trademarks are owned by the ViiV
Healthcare group
PM-GB-CBR-WCNT-230011 | March 2025
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.
If you are from outside the UK, you can report adverse events to GSK/ViiV by selecting your region and market, here.